[go: up one dir, main page]

HUP0101712A3 - Heterocyclic derivatives which inhibit factor xa and pharmaceutical compositions containing them - Google Patents

Heterocyclic derivatives which inhibit factor xa and pharmaceutical compositions containing them

Info

Publication number
HUP0101712A3
HUP0101712A3 HU0101712A HUP0101712A HUP0101712A3 HU P0101712 A3 HUP0101712 A3 HU P0101712A3 HU 0101712 A HU0101712 A HU 0101712A HU P0101712 A HUP0101712 A HU P0101712A HU P0101712 A3 HUP0101712 A3 HU P0101712A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
compositions containing
heterocyclic derivatives
inhibit factor
inhibit
Prior art date
Application number
HU0101712A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9809351.1A external-priority patent/GB9809351D0/en
Priority claimed from GBGB9903337.5A external-priority patent/GB9903337D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HUP0101712A2 publication Critical patent/HUP0101712A2/hu
Publication of HUP0101712A3 publication Critical patent/HUP0101712A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU0101712A 1998-05-02 1999-04-27 Heterocyclic derivatives which inhibit factor xa and pharmaceutical compositions containing them HUP0101712A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9809351.1A GB9809351D0 (en) 1998-05-02 1998-05-02 Heterocyclic derivatives
GBGB9903337.5A GB9903337D0 (en) 1999-02-16 1999-02-16 Heterocyclic derivatives
PCT/GB1999/001308 WO1999057113A1 (en) 1998-05-02 1999-04-27 Heterocyclic derivatives which inhibit factor xa

Publications (2)

Publication Number Publication Date
HUP0101712A2 HUP0101712A2 (hu) 2001-11-28
HUP0101712A3 true HUP0101712A3 (en) 2003-01-28

Family

ID=26313572

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101712A HUP0101712A3 (en) 1998-05-02 1999-04-27 Heterocyclic derivatives which inhibit factor xa and pharmaceutical compositions containing them

Country Status (22)

Country Link
US (2) US6753331B1 (hu)
EP (2) EP1528061A1 (hu)
JP (1) JP2002513790A (hu)
KR (1) KR20010043246A (hu)
CN (1) CN1133634C (hu)
AT (1) ATE282610T1 (hu)
AU (1) AU754453B2 (hu)
BR (1) BR9910179A (hu)
CA (1) CA2331042A1 (hu)
DE (1) DE69921994T2 (hu)
EE (1) EE200000527A (hu)
ES (1) ES2232131T3 (hu)
HU (1) HUP0101712A3 (hu)
IL (1) IL139406A (hu)
NO (1) NO320893B1 (hu)
NZ (1) NZ507835A (hu)
PL (1) PL343706A1 (hu)
PT (1) PT1082321E (hu)
SI (1) SI1082321T1 (hu)
SK (1) SK16512000A3 (hu)
TR (1) TR200003200T2 (hu)
WO (1) WO1999057113A1 (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
GB9902989D0 (en) * 1999-02-11 1999-03-31 Zeneca Ltd Heterocyclic derivatives
GB9914342D0 (en) * 1999-06-19 1999-08-18 Zeneca Ltd Compound
GB9917344D0 (en) * 1999-07-24 1999-09-22 Zeneca Ltd Novel salt
TWI288745B (en) 2000-04-05 2007-10-21 Daiichi Seiyaku Co Ethylenediamine derivatives
GB0012448D0 (en) 2000-05-24 2000-07-12 Astrazeneca Ab New process
CN100408099C (zh) * 2000-11-09 2008-08-06 阿斯特拉曾尼卡有限公司 含有嵌段共聚物的口服药物组合物
GB0104752D0 (en) * 2001-02-27 2001-04-18 Astrazeneca Ab Pharmaceutical compositions
WO2003000657A1 (en) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
WO2004108671A1 (en) * 2003-06-06 2004-12-16 Suven Life Sciences Limited Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
AU2004260758B2 (en) * 2003-08-01 2007-06-07 Nippon Soda Co., Ltd. Phenylazole compounds, production process, and antioxidants
SE0400014D0 (sv) 2004-01-08 2004-01-08 Astrazeneca Ab Heterocyclic derivatives
WO2007008144A1 (en) * 2005-07-08 2007-01-18 Astrazeneca Ab Heterocyclic sulfonamide derivatives as inhibitors of factor xa
WO2007008143A1 (en) * 2005-07-08 2007-01-18 Astrazeneca Ab Heterocyclic sulfonamide derivatives as inhibitors of factor xa
US20080221063A1 (en) * 2005-07-08 2008-09-11 Astrazeneca Ab Heterocyclic Sulfonamide Derivatives As Inhibitors Of Factor Xa
WO2007008145A1 (en) * 2005-07-08 2007-01-18 Astrazeneca Ab Heterocyclic sulfonamide derivatives as inhibitors of factor xa
SMT202200134T1 (it) 2018-03-08 2022-05-12 Incyte Corp Composti di amminopirazindiolo come inibitori di pi3k-y
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
US20220380478A1 (en) 2019-07-01 2022-12-01 Tonix Pharma Holdings Limited Anti-cd154 antibodies and uses thereof
EP4274587A1 (en) 2021-01-06 2023-11-15 Tonix Pharma Limited Methods of inducing immune tolerance with modified anti-cd154 antibodies
WO2025248134A1 (en) 2024-05-31 2025-12-04 Tonix Pharma Limited Treatment methods comprising administration of modified cd154 antibodies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115420A0 (en) * 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
ATE267011T1 (de) * 1995-12-21 2004-06-15 Bristol Myers Squibb Pharma Co Isoxazolin, isothiazolin und pyrazolin als faktor xa inhibitoren
GB9602166D0 (en) 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
GB9602294D0 (en) * 1996-02-05 1996-04-03 Zeneca Ltd Heterocyclic compounds
UA56197C2 (uk) 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
US6359134B1 (en) * 1997-05-30 2002-03-19 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
GB9715894D0 (en) * 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic derivatives
DE19743435A1 (de) * 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate

Also Published As

Publication number Publication date
AU754453B2 (en) 2002-11-14
NO320893B1 (no) 2006-02-06
NZ507835A (en) 2003-01-31
EP1528061A1 (en) 2005-05-04
US20040266759A1 (en) 2004-12-30
EP1082321A1 (en) 2001-03-14
DE69921994T2 (de) 2005-12-01
JP2002513790A (ja) 2002-05-14
CA2331042A1 (en) 1999-11-11
ATE282610T1 (de) 2004-12-15
HUP0101712A2 (hu) 2001-11-28
PL343706A1 (en) 2001-08-27
IL139406A0 (en) 2001-11-25
DE69921994D1 (de) 2004-12-23
KR20010043246A (ko) 2001-05-25
NO20005497L (no) 2000-12-21
SK16512000A3 (sk) 2001-05-10
ES2232131T3 (es) 2005-05-16
BR9910179A (pt) 2001-01-09
SI1082321T1 (en) 2005-06-30
WO1999057113A1 (en) 1999-11-11
TR200003200T2 (tr) 2001-02-21
EE200000527A (et) 2002-02-15
NO20005497D0 (no) 2000-11-01
US6753331B1 (en) 2004-06-22
IL139406A (en) 2004-07-25
AU3620699A (en) 1999-11-23
PT1082321E (pt) 2005-03-31
CN1133634C (zh) 2004-01-07
HK1034711A1 (en) 2001-11-02
CN1308631A (zh) 2001-08-15
EP1082321B1 (en) 2004-11-17

Similar Documents

Publication Publication Date Title
HUP0101810A3 (en) Substituted oxoazaheterocyclyl factor xa inhibitors and pharmaceutical compositions containing them
IL139479A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL148517A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL150077A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0101712A3 (en) Heterocyclic derivatives which inhibit factor xa and pharmaceutical compositions containing them
IL149883A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL149473A0 (en) Heterocyclic dihydropyrimidine derivatives and pharmaceutical compositions containing the same
IL145428A0 (en) Alkanoyl-substituted heterocyclic derivatives and pharmaceutical compositions containing the same
HUP0103256A3 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds
IL144592A0 (en) Heterocyclic aromatic compounds and pharmaceutical compositions containing the same
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL142665A0 (en) Acyl dipeptidyl derivatives and pharmaceutical compositions containing the same
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
IL138573A0 (en) Amide derivatives and pharmaceutical compositions containing the same
IL146540A0 (en) Thiazolo derivatives and pharmaceutical compositions containing them
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
HUP0003362A3 (en) Piperidine derivatives and pharmaceutical compositions containing them
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
HUP0002528A3 (en) Heterocyclic derivatives which inhibit factor xa
IL143802A0 (en) Imidazole derivatives and pharmaceutical compositions containing the same
IL157740A0 (en) Heterocyclic derivatives and pharmaceutical compositions containing the same
HUP0201714A3 (en) Substituted heterocyclic compounds and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees